Monday, July 13, 2020
Home Life Style Health & Fitness Vaccine For The Deadly Covid-19 Could be Ready by October, Says Pfizer...

Vaccine For The Deadly Covid-19 Could be Ready by October, Says Pfizer CEO

Pfizer believes that a vaccine to prevent Covid-19 could be ready by the end of October

Global pharmaceutical major Pfizer believes that a vaccine to prevent Covid-19 could be ready by the end of October, the company’s CEO Albert Bourla said. Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19 in collaboration with German mRNA company BioNTech. Bourla made the comments while participating at a virtual event organised by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) this week.

“If things go well and the stars are aligned, we will have enough evidence of safety and efficacy for us to feel comfortable, for the FDA (US Food and Drug Administration) to feel comfortable, and for the EMA (European Medicines Agency) to feel comfortable, to have a vaccine around the end of October,” Bourla was quoted as saying at the event by FierceBiotech. Speakers at the event also included AstraZeneca CEO Pascal Soriot, GlaxoSmithKline chief Emma Walmsley, Johnson & Johnson Chief Scientific Officer Paul Stoffels.

Each of these companies are working with their partners to develop a vaccine to prevent the disease. While GSK has joined forces with Sanofi, AstraZeneca is backing the vaccine being developed at the University of Oxford.

J&J is collaborating with the U.S. Biomedical Advanced Research and Development Authority to develop its vaccine. So far over 120 vaccines have been proposed across the world. Currently, there are at least 10 candidate vaccines in clinical evaluation and 115 candidate vaccines in pre-clinical evaluation.

vaccine
Pfizer is conducting clinical trials in the US and Europe for the BNT162 vaccine programme to prevent Covid-19. Wikimedia Commons

According to the WHO, it is important to evaluate as many vaccines as possible as we cannot predict how many will turn out to be viable. To increase the chances of success, it is critical to test all candidate vaccines until they fail, the WHO said. Pfizer and BioNTech’s development programme includes four vaccine candidates, each representing a different combination of mRNA format and target antigen. The novel design of the trial allows for the evaluation of the various mRNA candidates simultaneously in order to identify the safest and potentially most efficacious candidate in a greater number of volunteers, in a manner that will facilitate the sharing of data with regulatory authorities in real time.

“With our unique and robust clinical study program underway, starting in Europe and now the U.S., we look forward to advancing quickly and collaboratively with our partners at BioNTech and regulatory authorities to bring a safe and efficacious vaccine to the patients who need it most,” Bourla said in a statement earlier this month. “The short, less than four-month timeframe in which we’ve been able to move from pre-clinical studies to human testing is extraordinary and further demonstrates our commitment to dedicating our best-in-class resources, from the lab to manufacturing and beyond, in the battle against COVID-19,” he added.

Also Read: Manushi Chillar Expresses her Love for Wonder Woman on Instagaram

In anticipation of a successful clinical development programme, Pfizer and BioNTech are working to scale up production for global supply. The breadth of this programme should allow production of millions of vaccine doses in 2020, increasing to hundreds of millions in 2021, Pfizer said. (IANS)

STAY CONNECTED

18,989FansLike
362FollowersFollow
1,783FollowersFollow

Most Popular

Shilpa Shetty Shares Simple Yoga Tips to Beat Lockdown Muscle Stress

Months of being confined at home and the inability to go for a walk or hit the gym has led to stiffening of muscles...

Rising Diesel Prices Put Transport Sector at Disadvantage

Unexpected rise in diesel prices despite slower demand has put the transport sector at a big disadvantage as rising fuel cost has further shrunk...

85% Travelers Likely to Take a Road Trip This Summer: Report

Summer travel inarguably looks different this summer, and while domestic stays, road trips and flexible bookings look like the road ahead, there's a lot...

Mothers, Kids Lose 20% Health, Social Services During Pandemic: Study

Mothers, newborns, young children and adolescents are losing 20 per cent of their health and social services due to the Covid-19 pandemic, according to...

69% Indians Feel Need of Lockdown in 49 Districts: Survey

Worried over the rising number of cases, 69 per cent feel a stringent lockdown in 49 districts which have India's 80 per cent case...

Indian Railways to Go Carbon-Free by 2030

In a bid to make itself carbon-free by 2030, the Indian Railways has initiated a number of major initiatives to mitigate global warming and...

How Finance and Lifestyle Are Interlinked With Each Other

By Amanda Jerelyn When it comes to measuring and quantifying lifestyle, there is a broad range of things to consider. This can include diet, health, buying...

The Dynamic of Tibet and the Chinese Dream of Expansion

Tsering Woeser uses her blog named Invisible Tibet, together with her poetry and nonfiction and social media platforms like Twitter to give voice to...

Recent Comments